Skip to main content

Table 1 Descriptive data of the different methods used for the test and control groups (Ti = titanium and Zr = zirconia)

From: Effect of systemic antiresorptive medication on the histopathological parameters of implant osseointegration in an in vivo rodent study

 

Zoledronic acid Ti

Alendronic acid Ti

Control Ti

Zoledronic acid Zr

Alendronic acid Zr

Control Zr

Number of values

15

9

4

13

10

11

BIC ratio%

Minimum

19.14

2.00

10.80

28.97

788

12.50

Maximum

77.66

45.00

32.30

68.48

66.21

78.75

Mean

42.28

25.54

20.15

47.49

29.93

34.36

SD

18.47

14.77

8.93

11.38

23.30

19.65

Distance implant shoulder—bone mm

Minimum

1.00

0.75

0.50

0.20

0.40

0.30

Maximum

2.30

1.75

185

1.40

2.40

1.05

Mean

1.38

1.19

0.97

1.00

1.18

0.70

SD

0.37

0.32

0.61

0.35

0.59

0.22

New bone formation score

Minimum

0.50

0.00

0.50

0.50

0.50

0.00

Maximum

1.00

1.00

0.75

1.50

1.25

2.00

Mean

0.76

0.44

0.56

0.75

0.57

1.02

SD

0.24

0.39

0.12

0.32

0.23

0.56

Bone resorption score

Minimum

0.00

0.00

0.00

0.00

0.00

0.00

Maximum

1.00

1.00

1.00

1.00

1.00

1.00

Mean

0.28

0.77

0.62

0.23

0.15

0.59

SD

0.46

0.44

0.47

0.38

0.33

0.43

Bone necrosis score

Minimum

0.00

0.00

0.00

0.00

0.00

0.00

Maximum

0.00

0.00

0.00

0.00

1.00

0.00

Mean

0.00

0.00

0.00

0.00

0.20

0.00

SD

0.00

0.00

0.00

0.00

0.34

0.00

Signs of inflammation score

Minimum

0.00

0.00

0.00

0.00

0.00

0.50

Maximum

2.00

0.75

1.00

1.00

2.00

2.00

Mean

0.39

0.08

0.50

0.15

0.60

0.90

SD

0.62

0.25

0.57

0.31

0.69

0.43

Connective tissue proliferation score

Minimum

0.00

0.00

0.50

0.00

0.00

0.75

Maximum

2.50

1.75

1.25

1.75

2.00

2.00

Mean

0.75

0.55

0.87

0.65

1.15

1.29

SD

0.71

0.71

0.43

0.50

0.56

0.44